News | Image Guided Radiation Therapy (IGRT) | July 03, 2017

First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System

Advanced radiation therapy system dramatically improves precision, efficiency and safety while minimizing side effects

First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System

July 3, 2017 — Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS), announced that Montefiore doctors have treated the first cancer patients in New York with the advanced Radixact Treatment Delivery System. The system was designed to deliver image-guided intensity-modulated (IG-IMRT) radiation therapy, an extremely precise form of radiation therapy. Montefiore is the only hospital in New York State, and in the greater New York area, to have this equipment.

The Radixact System is the next-generation TomoTherapy platform developed to enable doctors to more efficiently and effectively deliver precise radiation treatments to more patients with cancer every day. What makes the Radixact technology different from conventional radiation systems is the integration of a computed tomography (CT) scanner with the radiation therapy delivery system. The built-in CT scanner performs daily imaging before each treatment session to determine the shape and position of the tumor. This allows for accurate and precise tumor targeting, while reducing the radiation dose to normal, healthy tissue. Only then, is radiation delivered from 360 degrees around the patient's body allowing for treatment of any target, irrespective of its length. 

Daily pretreatment imaging, coupled with the system's Accuray Precision Treatment Planning System and PreciseART Adaptive Radiation Therapy software, informs precise treatment planning and mid-course decision-making, so clinical teams can instantly adapt therapy to:

  • Changes in tumor size, shape and location; and
  • Subtle changes in the location of organs and other healthy tissue, due to weight gain or loss

Identifying and correcting for any variations in patient positioning, as well as biological changes, ensures the continued precision and safe delivery of the radiation dose to the target area, resulting in fewer long term side effects.

The Radixact System is capable of treating all standard radiation therapy indications including breast, head and neck, lung and prostate cancers, in addition to complex treatments such as total marrow irradiation. The Montefiore patients were treated for prostate cancer, and plans are also in place to use the system for patients with Ob/Gyn-related cancers and head and neck cancers, as these often require alterations to therapy mid-course due to changes in tumor size, location and individual weight.

"We could not be more thrilled to have this amazing technology here at Montefiore, along with the clinical expertise to guide its use," said Shalom Kalnicki, M.D., FACRO, professor and chair, Department of Radiation Oncology, Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine. "We know the ability to adapt the radiation dose to the actual target and normal tissue position and shape is key to the future of radiation therapy. This technology is so sophisticated it can streamline treatment so cures are more frequent and patients are better protected from side effects they have suffered in the past. The Radixact System is an exciting step forward solidifying the Montefiore Einstein Center for Cancer Care's place on the frontier of cancer treatment."

According to the Centers for Disease Control and Prevention (CDC), the state of New York has the third highest cancer rate in the United States. More than 105,000 people in New York are diagnosed with cancer each year, or approximately 287 people each day. Innovations such as the Radixact System are helping to make it possible for people who are diagnosed with cancer to live longer with a better quality of life than was previously possible.

For more information: www.accuray.com

Related Content

Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer
A special issue of the Journal of Medical Imaging and Radiation Sciences features stories about the interpersonal skills beyond the technical aspects to care for and guide patients through medical imaging and radiation therapy procedures

Image courtesy of Canon

News | Patient Engagement | August 11, 2020
August 11, 2020 — "I went into the MRI
Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...